Japanese Researchers Discover Frog Gut Bacteria with Potent Anticancer Properties
By
Xunxi
Properly proved. Has structure, has flavour, has a point.
Summary
Japanese researchers at JAIST have discovered that Ewingella americana bacteria from Japanese tree frog intestines shows potent anticancer activity, achieving complete tumor elimination in mouse models. The research, published in Gut Microbes, demonstrates that this gut bacterium from amphibians can directly kill cancer cells through a novel mechanism, offering potential for new cancer therapies.
Key quotes
· 3 pulledA research team of Prof. Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST) has discovered that the bacterium Ewingella americana, isolated from the intestines of Japanese tree frogs (Dryophytes japonicus), possesses remarkably potent anticancer activity.
This groundbreaking research has been published in the international journal Gut Microbes.
While the relationship between gut microbiota and cancer has attracted considerable attention in recent years, most approaches have focused on indirect methods.
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·4h ago
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
biotechniques.com·5h ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·7h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·11h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·11h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·11h ago